We are live on ! Find out more
HSA

Hussman Strategic Advisors Portfolio holdings

AUM $463M
1-Year Est. Return 16%
This Fund
S&P 500
This Quarter Est. Return
-5.22%
1 Year Est. Return
+16%
3 Year Est. Return
+35.45%
5 Year Est. Return
+32.62%
10 Year Est. Return
+255.18%
AUM
$338M
AUM Growth
-$68.7M
Cap. Flow
-$46.3M
Cap. Flow %
-13.68%
Top 10 Hldgs %
14.46%
Holding
318
New
102
Increased
37
Reduced
46
Closed
84

Top Buys

Rank Stock Value
1
PTGX icon
Protagonist Therapeutics
PTGX
+$4.58M
2
CL icon
Colgate-Palmolive
CL
+$4.01M
3
CPB icon
Campbell Soup
CPB
+$3.8M
4
CI icon
Cigna
CI
+$3.35M
5
OGN icon
Organon & Co
OGN
+$3.08M

Top Sells

Rank Stock Value
1
IONQ icon
IonQ
IONQ
+$9.74M
2
AEM icon
Agnico Eagle Mines
AEM
+$8.41M
3
B
Barrick Mining
B
+$7.88M
4
NEM icon
Newmont
NEM
+$5.81M
5
META icon
Meta Platforms (Facebook)
META
+$4.93M

Sector Composition

Rank Sector Weight
1 Healthcare 27.3%
2 Consumer Staples 13.52%
3 Financials 13.44%
4 Consumer Discretionary 13.24%
5 Technology 11.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CPB icon
1
Campbell Soup
CPB
$6.51B
$6.16M 1.82%
147,000
+84,000
+133% +$3.8M
CL icon
2
Colgate-Palmolive
CL
$72.6B
$6.11M 1.8%
67,200
+42,000
+167% +$4.01M
VZ icon
3
Verizon
VZ
$194B
$5.88M 1.74%
147,000
+63,000
+75% +$2.66M
NVO
4
Novo Nordisk
NVO
$216B
$5.42M 1.6%
63,000
+12,600
+25% +$1.36M
NRG icon
5
NRG Energy
NRG
$29.8B
$4.87M 1.44%
54,000
+10,500
+24% +$973K
QCOM icon
6
Qualcomm
QCOM
$176B
$4.84M 1.43%
31,500
-6,300
-17% -$1.03M
PTGX icon
7
Protagonist Therapeutics
PTGX
$8.75B
$4.05M 1.2%
+105,000
New +$4.58M
GIS icon
8
General Mills
GIS
$19.2B
$4.02M 1.19%
63,000
+31,500
+100% +$2.11M
AMGN icon
9
Amgen
AMGN
$203B
$3.83M 1.13%
14,700
+4,200
+40% +$1.25M
DVA icon
10
DaVita
DVA
$15.1B
$3.77M 1.11%
25,200
+16,800
+200% +$2.63M
C icon
11
Citigroup
C
$222B
$3.7M 1.09%
52,500
+10,500
+25% +$708K
HALO icon
12
Halozyme
HALO
$9.72B
$3.51M 1.04%
73,500
+31,500
+75% +$1.62M
B
13
Barrick Mining
B
$62.2B
$3.16M 0.93%
204,000
-433,500
-68% -$7.88M
HCA icon
14
HCA Healthcare
HCA
$84.8B
$3.15M 0.93%
10,500
+4,200
+67% +$1.47M
GCT icon
15
GigaCloud Technology
GCT
$1.35B
$3.11M 0.92%
168,000
– –
SN icon
16
SharkNinja
SN
$21B
$3.07M 0.91%
31,500
+14,700
+88% +$1.5M
FLO icon
17
Flowers Foods
FLO
$1.64B
$3.04M 0.9%
147,000
+42,000
+40% +$923K
ALLY icon
18
Ally Financial
ALLY
$13.1B
$3.02M 0.89%
84,000
+21,000
+33% +$763K
UHS icon
19
Universal Health Services
UHS
$9.43B
$3.01M 0.89%
16,800
+12,600
+300% +$2.57M
UTHR icon
20
United Therapeutics
UTHR
$26.3B
$2.96M 0.88%
8,400
+2,100
+33% +$772K
MPC icon
21
Marathon Petroleum
MPC
$90.3B
$2.93M 0.87%
21,000
+14,700
+233% +$2.24M
INVA icon
22
Innoviva
INVA
$1.58B
$2.91M 0.86%
168,000
+42,000
+33% +$806K
INCY icon
23
Incyte
INCY
$23.5B
$2.9M 0.86%
+42,000
New +$2.99M
CI icon
24
Cigna
CI
$76.6B
$2.9M 0.86%
+10,500
New +$3.35M
HRMY icon
25
Harmony Biosciences
HRMY
$2.04B
$2.89M 0.85%
84,000
+21,000
+33% +$722K
1
2 3 4 5

Similar funds

CPIM
Coalescence Partners Investment Management New York $463M AUM 8.27% 1-Year Est. Return
SHWM
Smith & Howard Wealth Management Atlanta, Georgia $462M AUM 12.39% 1-Year Est. Return
CWWM
Clear Wave Wealth Management Red Bank, New Jersey $463M AUM
SWMG
Sanchez Wealth Management Group Jacksonville, Florida $462M AUM 13.82% 1-Year Est. Return
NG
NatWest Group Edinburgh, Scotland, United Kingdom $462M AUM 47.31% 1-Year Est. Return
PC
ParaFi Capital New York $462M AUM 12.81% 1-Year Est. Return
AC
Aristides Capital Louisville, Kentucky $462M AUM 28.94% 1-Year Est. Return
PRCP
Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return

Hussman Strategic Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Hussman Strategic Advisors held 318 positions worth $338M, down 17% from $407M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Hussman Strategic Advisors withdrew a net $46.3M in Q4 2024, closing 84 positions and reducing 46 holdings. Its most notable exit was Buckle, an estimated $3.69M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 19% a quarter earlier, followed by Consumer Staples and Financials.

Against the trend, Hussman Strategic Advisors opened a new position in Protagonist Therapeutics worth $4.05M.

  • Hussman Strategic Advisors's largest Q4 2024 buy was Protagonist Therapeutics: 105,000 shares worth $4.05M.
  • Hussman Strategic Advisors added most to Colgate-Palmolive in Q4 2024, an estimated $4.01M increase.
  • Hussman Strategic Advisors's biggest Q4 2024 reduction was IonQ, cutting an estimated $9.74M.
  • Hussman Strategic Advisors fully exited Buckle in Q4 2024, selling an estimated $3.69M.
  • Hussman Strategic Advisors's ten largest holdings make up 14% of its $338M portfolio in Q4 2024.
  • Hussman Strategic Advisors opened 102 new positions and closed 84 in Q4 2024.
  • Hussman Strategic Advisors's portfolio value fell 17% quarter-over-quarter to $338M.

Based on Hussman Strategic Advisors's 13F filing for Q4 2024, filed 3 Feb 2025.